Muscle Pharm Corp (fka MSLPQ)

[Rhenarium]

bellator is - for now, and for reasons known only to him - being deliberately obtuse. He is far too intelligent snd investment-savvy to believe the twaddle he is posting, to wit:

- God commanded that fair value for any company is always 1x revenue while EPS, EPS growth, revenue growth, FCF, and FCF growth are irrelevant for valuation purposes;
- We should expect ongoing repetition of the 50%+ dilution resulting from the issuance of millions of shares to recapitalize the company when it was essentially insolvent and had O/S of a few million shares (best dilution EVER!;
- We should expect ongoing repetition of the dilution associated from the partnership with Arnold (best dilution EVER, other than the Frost dilution that saved the company)
- We should expect ongoing repetition of the dilution associated with the BZNE acquisition (I have concerns about this one, but only time will tell)
- Advertising and celebrity endorsements are a waste of money - it is clearly the incredible efficacy of MSLP products that is responsible for the company's rapid growth is sales and market share

I could go on, but my fingers are getting tired...